Jul 10, 2026 | BioStem in the News
POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft...
Jul 29, 2026 | BioStem in the News
POMPANO BEACH, Fla., July 29, 2026 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft...
Jul 8, 2026 | BioStem in the News
Company Continues to Expand Intellectual Property Portfolio Supporting Advanced Placental Allograft Innovation POMPANO BEACH, FL / ACCESS Newswire / July 8, 2026 / BioStem Technologies, Inc. (OTCID:BSEM), a leading regenerative medicine company focused on the...
Jun 10, 2026 | BioStem in the News
POMPANO BEACH, Fla., June 10, 2026 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that...
Jun 9, 2026 | BioStem in the News
POMPANO BEACH, Fla., June 09, 2026 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the...
Mar 11, 2026 | BioStem in the News
POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative medicine, today...
